Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Other Non Operating Income (2014 - 2026)

Viking Therapeutics' (VKTX) quarterly Other Non Operating Income came in at $4.6 million in Q2 2026, down 49.24% year-over-year from $9.0 million in Q2 2025, and down 21.12% quarter-over-quarter from $5.8 million in Q1 2026.

Analysis

Viking Therapeutics (VKTX) Other Non Operating Income (2014 - 2026) Analysis & Trends

Viking Therapeutics has disclosed Other Non Operating Income across 13 years of filings, most recently posting $4.6 million for Q2 2026.

  • In Q2 2026, Other Non Operating Income fell 49.24% year-over-year to $4.6 million; the TTM figure through Jun 2026 stood at $25.2 million (down 38.91% YoY), while the FY2025 annual figure was $33.7 million, down 17.71% from the prior year.
  • Other Non Operating Income came in at $4.6 million for Q2 2026 at Viking Therapeutics, down from $5.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $11.8 million in Q2 2024 to a low of $142000.0 in Q1 2022.
  • Average Other Non Operating Income over 5 years is $5.6 million, with a median of $5.3 million recorded in 2023.
  • Year-over-year, Other Non Operating Income soared 2168.84% in 2023 and plunged 49.24% in 2026.
  • Over 5 years, Other Non Operating Income stood at $724000.0 in 2022, then surged by 546.41% to $4.7 million in 2023, then soared by 131.22% to $10.8 million in 2024, then sank by 34.61% to $7.1 million in 2025, then slumped by 35.34% to $4.6 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were $4.6 million in Q2 2026, $5.8 million in Q1 2026, and $7.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Viking Therapeutics 4.86 Bn 4.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.58 Mn
Mar 31, 2026 5.80 Mn
Dec 31, 2025 7.08 Mn
Sep 30, 2025 7.77 Mn
Jun 30, 2025 9.01 Mn
Mar 31, 2025 9.84 Mn
Dec 31, 2024 10.82 Mn
Sep 30, 2024 11.62 Mn
Jun 30, 2024 11.80 Mn
Mar 31, 2024 6.72 Mn
Dec 31, 2023 4.68 Mn
Sep 30, 2023 4.73 Mn
Jun 30, 2023 4.52 Mn
Mar 31, 2023 1.01 Mn
Dec 31, 2022 724,000.00
Sep 30, 2022 423,000.00
Jun 30, 2022 199,000.00
Mar 31, 2022 142,000.00
Dec 31, 2021 154,000.00
Sep 30, 2021 160,000.00
API Access

Viking Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=VKTX&period=max&api_key=YOUR_API_KEY